GlassScriptPhysician profile
George M Harris
NPI 1467487843
$10,012.15
in general payments reported to CMS, 2019-2025
48 companies · $1,785 in 2025
The $1,785 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $597 · 2020: $948 · 2021: $1,912 · 2022: $1,284 · 2023: $1,960 · 2024: $1,526 · 2025: $1,785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,271.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,412.77 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $996.24 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $992.78 | 2020-2025 | |
| Pfizer INC. | $846.90 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $572.33 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $553.97 | 2019-2025 | Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $553.30 | 2020-2025 | Farxiga, Airsupra, Breztri |
| Janssen Pharmaceuticals, INC | $517.22 | 2019-2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $425.04 | 2022-2025 | |
| Amarin Pharma, INC. | $412.14 | 2020-2022 | |
| Exact Sciences Corporation | $331.30 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $262.29 | 2019-2025 | Otezla, Repatha, Evenity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $229.20 | 2019-2024 | Xifaxan |
| Otsuka America Pharmaceutical, INC. | $220.04 | 2022-2025 | Rexulti |
| Merck Sharp & Dohme LLC | $146.00 | 2019-2025 | Lagevrio |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.